PulseAugur
EN
LIVE 20:32:10

Mastodon user jokes about hair loss treatment trial and stock surge

A user on Mastodon shared a link to a Morningstar article about Absci's stock performance following a trial for a hair loss treatment. The user humorously suggested they would take the treatment with no side effects, noting a significant increase in company value. AI

RANK_REASON The item is a social media post with a humorous take on a news article, not a primary news event.

Read on Mastodon — fosstodon.org →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Mastodon user jokes about hair loss treatment trial and stock surge

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Meme
The item is a social media post with a humorous take on a news article, not a primary news event.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
100 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Mastodon — fosstodon.org TIER_1 English(EN) · bmjhayward ·

    I would take this jab, ngl no serious side effects and of course company values went _way_ up like _bigly_ https://www. morningstar.com/news/dow-jones /20260624

    I would take this jab, ngl no serious side effects and of course company values went _way_ up like _bigly_ https://www. morningstar.com/news/dow-jones /202606243000/absci-reports-data-from-trial-for-hair-loss-treatment-prices-100-million-stock-offering # ai # absci # drugdesign #…